Events

Safety Alert for Plum A+ infusion pumps and Plum A+3 infusion pumps

According to Department of Health, this safety alert involved a device in Hong Kong that was produced by Hospira Inc.

What is this?

Alerts provide important information and recommendations about products. Even though an alert has been issued, it does not necessarily mean a product is considered to be unsafe. Safety Alerts, addressed to health workers and users, may include recalls. They can be written by manufacturers, but also by health officials.

Learn more about the data here
  • Type of Event
    Safety alert
  • Date
    2015-03-06
  • Event Date Posted
    2015-03-06
  • Event Country
    Hong Kong
  • Event Source
    DH
  • Event Source URL
    https://www.mdco.gov.hk/english/safety/recalls/recalls_20150306a.html
  • Notes / Alerts
    Hong Kong data is current through September 2018. All of the data comes from the Department of Health (Hong Kong), except for the categories Manufacturer Parent Company and Product Classification.
    The Parent Company and the Product Classification were added by ICIJ.
    The parent company information is based on 2017 public records. The device classification information comes from FDA’s Product Classification by Review Panel, based on matches of data from the U.S. and Hong Kong.
    ICU Medical, Inc. acquired from Pfizer in early 2017, Hospira Infusion Systems, the portion of Hospira dedicated to develop infusion pumps.
  • Extra notes in the data
    Medical Device Safety Alert
  • Reason
    Medical device safety alert: hospira plum a+ infusion pumps and plum a+3 infusion pumps the united states food and drug administration (fda) posted a medical device safety alert concerning plum a+ infusion pumps and plum a+3 infusion pumps [list numbers: 11005 and 20678. serial numbers: refer to the link below] manufactured by hospira inc. the manufacturer is initiating a recall as the system alarms which should sound when a therapy is interrupted may fail to sound. it is possible for a long delay before a health care professional becomes aware of the need to restore therapy. for patients receiving critical intravenous medication, there is a risk of injury resulting from this potential prolonged interruption in therapy. for details, please refer to the following link: http://www.Fda.Gov/medicaldevices/safety/listofrecalls/ucm436770.Htm according to the local supplier, the affected products are not distributed in hong kong. if you are in possession of the affected products, please contact your supplier for necessary actions. posted on 06 march 2015.

Device

Plum A+ infusion pumps and Plum A+3 infusion pumps

Manufacturer

Hospira Inc
  • Manufacturer Parent Company (2017)
    Pfizer
  • Source
    DH